194 related articles for article (PubMed ID: 30233306)
1. Integrated Analysis Reveals Altered Lipid and Glucose Metabolism and Identifies NOTCH2 as a Biomarker for Parkinson's Disease Related Depression.
Dong MX; Feng X; Xu XM; Hu L; Liu Y; Jia SY; Li B; Chen W; Wei YD
Front Mol Neurosci; 2018; 11():257. PubMed ID: 30233306
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolic dysregulation is involved in Parkinson's disease dementia.
Dong MX; Wei YD; Hu L
Metab Brain Dis; 2021 Mar; 36(3):463-470. PubMed ID: 33433787
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics profiling reveals altered lipid metabolism and identifies a panel of lipid metabolites as biomarkers for Parkinson's disease related anxiety disorder.
Dong MX; Hu L; Wei YD; Chen GH
Neurosci Lett; 2021 Feb; 745():135626. PubMed ID: 33440238
[TBL] [Abstract][Full Text] [Related]
4. Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson's Disease.
Hu L; Dong MX; Huang YL; Lu CQ; Qian Q; Zhang CC; Xu XM; Liu Y; Chen GH; Wei YD
Front Mol Neurosci; 2020; 13():80. PubMed ID: 32714143
[TBL] [Abstract][Full Text] [Related]
5. Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.
Zhao H; Wang C; Zhao N; Li W; Yang Z; Liu X; Le W; Zhang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():101-108. PubMed ID: 29518718
[TBL] [Abstract][Full Text] [Related]
6. Cognitive profiles and optimal cut-offs for routine cognitive tests in elderly individuals with Parkinson's disease, Parkinson's disease dementia, Alzheimer's disease, and normal cognition.
Phannarus H; Muangpaisan W; Siritipakorn P; Chotinaiwattarakul W
Psychogeriatrics; 2020 Jan; 20(1):20-27. PubMed ID: 30912230
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Plasma FAM19A5 and MRI-Based Radiomics Model for Prediction of Parkinson's Disease and Parkinson's Disease With Depression.
Li XN; Hao DP; Qu MJ; Zhang M; Ma AB; Pan XD; Ma AJ
Front Neurosci; 2021; 15():795539. PubMed ID: 34975391
[No Abstract] [Full Text] [Related]
8. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
9. Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson's disease dementia brain.
Scholefield M; Church SJ; Taylor G; Knight D; Unwin RD; Cooper GJS
NPJ Parkinsons Dis; 2023 Apr; 9(1):66. PubMed ID: 37081022
[TBL] [Abstract][Full Text] [Related]
10. Plasma proteome profiling using tandem mass tag labeling technology reveals potential biomarkers for Parkinson's disease: a preliminary study.
Zhao Y; Zhang Y; Zhang J; Yang G
Proteomics Clin Appl; 2022 Mar; 16(2):e2100010. PubMed ID: 34791804
[TBL] [Abstract][Full Text] [Related]
11. QEEG indices are associated with inflammatory and metabolic risk factors in Parkinson's disease dementia: An observational study.
Liu H; Deng B; Zhou H; Wu Z; Chen Y; Weng G; Zhu S; Xu J; Wang H; Zhou Z; Tan EK; Wang Q
EClinicalMedicine; 2022 Oct; 52():101615. PubMed ID: 36034410
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
13. High Performance Liquid Chromatography-Mass Spectrometry (LC-MS) Based Quantitative Lipidomics Study of Ganglioside-NANA-3 Plasma to Establish Its Association with Parkinson's Disease Patients.
Zhang J; Zhang X; Wang L; Yang C
Med Sci Monit; 2017 Nov; 23():5345-5353. PubMed ID: 29123078
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of tear fluid reveals disease-specific patterns in patients with Parkinson's disease - A pilot study.
Boerger M; Funke S; Leha A; Roser AE; Wuestemann AK; Maass F; Bähr M; Grus F; Lingor P
Parkinsonism Relat Disord; 2019 Jun; 63():3-9. PubMed ID: 30876839
[TBL] [Abstract][Full Text] [Related]
15. Serum metabolomics analysis revealed metabolic disorders in Parkinson's disease.
Lan TT; Chang L; Hou LW; Wang ZZ; Li DC; Ren ZH; Gu T; Wang JW; Chen GS
Medicine (Baltimore); 2023 Jun; 102(23):e33715. PubMed ID: 37335671
[TBL] [Abstract][Full Text] [Related]
16. Fasting glucose variability and risk of dementia in Parkinson's disease: a 9-year longitudinal follow-up study of a nationwide cohort.
Kang SH; Choi Y; Chung SJ; Moon SJ; Kim CK; Kim JH; Oh K; Yoon JS; Seo SW; Cho GJ; Koh SB
Front Aging Neurosci; 2023; 15():1292524. PubMed ID: 38235038
[TBL] [Abstract][Full Text] [Related]
17. Potential Metabolomic Linkage in Blood between Parkinson's Disease and Traumatic Brain Injury.
Fiandaca MS; Gross TJ; Johnson TM; Hu MT; Evetts S; Wade-Martins R; Merchant-Borna K; Bazarian J; Cheema AK; Mapstone M; Federoff HJ
Metabolites; 2018 Sep; 8(3):. PubMed ID: 30205491
[TBL] [Abstract][Full Text] [Related]
18. Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease.
Santiago JA; Littlefield AM; Potashkin JA
Sci Rep; 2016 Sep; 6():34579. PubMed ID: 27680512
[TBL] [Abstract][Full Text] [Related]
19. Integrated metabolomics and proteomics analysis of plasma lipid metabolism in Parkinson's disease.
Gątarek P; Kałużna-Czaplińska J
Expert Rev Proteomics; 2024; 21(1-3):13-25. PubMed ID: 38346207
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
